Pear Therapeutics, Inc. Reports Net Loss of $75.5 Million in 2022
The Digital Therapeutics Company Records Revenue of $12.7 Million for the Year
By USInMinutes
Published - Jul 24, 2023, 07:50 AM ET
Last Updated - Jul 24, 2023, 07:50 AM EDT
Pear Therapeutics, Inc.(PEARQ), a leading digital therapeutics company, has released its consolidated financial statements for the year ended December 31, 2022. The report reveals both its net income/loss and revenue figures, providing insight into the company's financial performance during the specified period.
Net Loss in 2022
Pear Therapeutics, Inc. experienced a net loss of $75.5 million in 2022. This loss reflects the financial challenges faced by the company during the year, as it worked towards advancing its digital therapeutic solutions in the healthcare market.
Revenue Growth
